Average Co-Inventor Count = 7.00
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ipsen Biopharm Limited (5 from 41 patents)
2. Merrimack Pharmaceuticals, Inc. (4 from 52 patents)
9 patents:
1. 12364691 - Methods for treating pancreatic cancer using combination therapies
2. 11369597 - Methods for treating pancreatic cancer using combination therapies
3. 11344552 - Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
4. 10980795 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
5. 9717724 - Methods for treating pancreatic cancer using combination therapies
6. 9492442 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
7. 9452162 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
8. 9364473 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
9. 9339497 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan